• Elina Khattab
  Medical School, University of Cyprus, Nicosia, Cyprus
• Eirini Christaki
  Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece
• Constantinos Pitsios
  Medical School, University of Cyprus, Nicosia, Cyprus

Keywords

COVID-19, SARS-CoV-2, vaccination, pityriasis rosea

Abstract

It is increasingly recognized that SARS-CoV-2 infection and COVID-19 vaccines have been associated with skin disorders, including pityriasis rosea. It has been reported that pityriasis rosea has been triggered by several vaccines, as a rare side-effect. We present two cases of COVID-19 vaccine-induced pityriasis rosea. Skin lesions appeared in a 49-year-old female 8 days after the first dose of the BNT162b2 mRNA vaccine and in a 53-year-old male 7 days after the second dose of the same vaccine. The exanthem was self-limited in both patients over a period of a month.

Views: 1373
HTML downloads: 285
PDF downloads: 793

Published: 2022-02-03
Issue: 2022: Vol 9 No 2 (view)